- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01905982
The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV; part2
June 17, 2019 updated by: Klaus Kenn, Schön Klinik Berchtesgadener Land
The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy on Dyspnoea, Activity and Parasympathetic Activities in Patients With COPD III-IV
The purpose of this study is to determine whether different types of breathing therapies in patients with COPD III-IV decrease dyspnea, increase activity and have impact on parasympathetic activities.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bayern
-
Schönau, Bayern, Germany, 83471
- Recruiting
- Schön Klinik Berchtesgadener Land
-
Contact:
- Klaus Kenn, Prof.
- Phone Number: 1540 0049865293
- Email: kkenn@schoen-kliniken.de
-
Contact:
- Tessa Schneeberger, MSc
- Phone Number: 2730 0049865293
- Email: tschneeberger@schoen-kliniken.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
46 years to 71 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- inpatient rehabilitation
- COPD (Gold stage III and IV)
Exclusion Criteria:
- severe exacerbation in the last four weeks
- acute infections
- fever
- neuritides
- severe osteoporosis
- skin disease
- manic depression
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Conventional breathing therapy
first: conventional breathing therapy, second: reflectory breathing therapy
|
duration:4x30 minutes
|
|
Experimental: Reflectory breathing therapy
first: Reflectory breathing therapy second:Conventional breathing therapy
|
duration:2x60 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in BORG-Scale
Time Frame: Change from pre (minute 0) in Borg Scale and directly post intervention
|
Instrument for self-reported dyspnea; modified BORG-scale ranges from 1 (no dyspnea) to 10 (maximum dyspnea)
|
Change from pre (minute 0) in Borg Scale and directly post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in lung volume
Time Frame: change from pre (minute0) in residual volume to post intervention
|
measured by a bodyplethysmograph
|
change from pre (minute0) in residual volume to post intervention
|
|
physical activity
Time Frame: 48 h post intervention
|
measured by Senswear
|
48 h post intervention
|
|
parasympathetic activities
Time Frame: baseline and post intervention
|
measured via Biofeedback
|
baseline and post intervention
|
|
Chronic Respiratory Questionnaire
Time Frame: baseline and post intervention
|
health related quality of life
|
baseline and post intervention
|
|
COPD Assessment Test
Time Frame: baseline and post intervention
|
health related Quality of life
|
baseline and post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Klaus Kenn, Prof. Dr., Schön Klinik Berchtesgadener Land
- Principal Investigator: Tessa Schneeberger, Schön Klinik Berchtesgadener Land
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2016
Primary Completion (Anticipated)
December 1, 2019
Study Completion (Anticipated)
March 1, 2020
Study Registration Dates
First Submitted
July 19, 2013
First Submitted That Met QC Criteria
July 22, 2013
First Posted (Estimate)
July 23, 2013
Study Record Updates
Last Update Posted (Actual)
June 18, 2019
Last Update Submitted That Met QC Criteria
June 17, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RAT 2013
- KBerchtesgadener (Registry Identifier: KBerchtesgadener)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University Hospital, GhentGlaxoSmithKline; University GhentCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium
-
Optimum Patient CareRespiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (13645005)United States
-
Poitiers University HospitalCompletedBroncho Chronic Obstructive Pulmonary DiseaseFrance
Clinical Trials on conventional breathing therapy
-
Schön Klinik Berchtesgadener LandUniversity of OsnabrueckCompletedChronic Obstructive Pulmonary DiseaseGermany
-
Istanbul Medipol University HospitalCompleted
-
Riphah International UniversityRecruiting
-
Atlas UniversityCompleted
-
The Second Hospital of Hebei Medical UniversityCompletedStroke | Lung DiseasesChina
-
Hasan Kalyoncu UniversityCompletedLow Back Pain | Anxiety | Sleep HygieneTurkey
-
Bandırma Onyedi Eylül UniversityActive, not recruitingQuality of Life | Pain | Frozen ShoulderTurkey
-
Foundation University IslamabadCompleted
-
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training...Not yet recruitingCervicogenic HeadacheTurkey (Türkiye)
-
Riphah International UniversityCompleted